What is the Impact Factor of Therapeutic Drug Monitoring?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Therapeutic Drug Monitoring is 2.30, ranking in quartile Q2 of Web of Science (SCIE).

Is Therapeutic Drug Monitoring indexed in Web of Science or Scopus?

Yes, Therapeutic Drug Monitoring is indexed in Web of Science (SCIE, Q2 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.587 (Q2) and an H-index of 108.

Who publishes Therapeutic Drug Monitoring and what is the Article Processing Charge (APC)?

Therapeutic Drug Monitoring is published by Lippincott Williams and Wilkins Ltd.. The estimated Article Processing Charge (APC) is approximately $2,988 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Therapeutic Drug Monitoring?

The official ISO-4 abbreviation of Therapeutic Drug Monitoring is "THER. DRUG MONIT" with common acronym "tdm". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q2Scopus Q2SCImago #10,089Hybrid

Therapeutic Drug Monitoring

Acronym:tdm

•

Abbreviation (ISO):THER. DRUG MONIT

•

Identifier (ISSN):0163-4356(Print)/1536-3694(Online)

•

Publisher:Lippincott Williams and Wilkins Ltd.

Official Website Submission Portal Compare

Clarivate IF (2026)

2.3↓ -0.1

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Therapeutic Drug Monitoring

WoS Q2

Annual Impact Factor Metric

Current (2026):2.3

Scopus SJR & RankScopus Q2

0.587

#10,089

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

108

108 papers with at least that number of citations each

WoS: SCIE / JCRQ2

Self-Citation Rate7.1%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

94articles/year

23.29% Gold OA•70.93% Original Research

Aims & Scope

Therapeutic Drug Monitoring is a peer-reviewed, multidisciplinary journal directed to an audience of pharmacologists, clinical chemists, laboratorians, pharmacists, drug researchers and toxicologists. It fosters the exchange of knowledge among the various disciplines–clinical pharmacology, pathology, toxicology, analytical chemistry–that share a common interest in Therapeutic Drug Monitoring. The journal presents studies detailing the various factors that affect the rate and extent drugs are absorbed, metabolized, and excreted. Regular features include review articles on specific classes of drugs, original articles, case reports, technical notes, and continuing education articles.

Topics Covered (Recognized by AI)

Medicine93.9%Biology88.9%Internal medicine81%Chemistry72.1%Pharmacology70.2%Psychology51.1%Psychiatry48.4%Bioinformatics47.9%Biochemistry47.8%Pharmacokinetics46.5%Endocrinology45%Genetics44.9%Organic chemistry40%Chromatography31.4%Drug31%Surgery29.5%Physics26.1%Therapeutic drug monitoring22.8%Mathematics20.8%Immunology20.1%Pathology20.1%

Primary Research Areas

Medicine Toxicology

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

MEDICAL LABORATORY TECHNOLOGY

Rank14/33

IndexSCIE

JCRSCIE2026

PHARMACOLOGY & PHARMACY

Rank226/356

IndexSCIE

JCRSCIE2026

TOXICOLOGY

Rank78/106

IndexSCIE

JCISCIE2026

MEDICAL LABORATORY TECHNOLOGY

Rank20/33

IndexSCIE

JCISCIE2026

PHARMACOLOGY & PHARMACY

Rank186/356

IndexSCIE

JCISCIE2026

TOXICOLOGY

Rank64/106

IndexSCIE

Category	Index	Rank	Quartile
MEDICAL LABORATORY TECHNOLOGY	JCRSCIE	14/33	Q2
PHARMACOLOGY & PHARMACY	JCRSCIE	226/356	Q3
TOXICOLOGY	JCRSCIE	78/106	Q3
MEDICAL LABORATORY TECHNOLOGY	JCISCIE	20/33	Q3
PHARMACOLOGY & PHARMACY	JCISCIE	186/356	Q3
TOXICOLOGY	JCISCIE	64/106	Q3

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF2.3

Articles / Year89

Total Citations22

2025

IF2.4

Articles / Year129

Total Citations183

2024

IF2.8

Articles / Year161

Total Citations487

2023

IF2.5

Articles / Year111

Total Citations844

2022

IF3.118

Articles / Year95

Total Citations729

Year	Impact Factor	Articles / Year	Total Citations
2026	2.3	89	22
2025	2.4	129	183
2024	2.8	161	487
2023	2.5	111	844
2022	3.118	95	729
2021	3.681	91	1,322
2020	2.073	141	2,508
2019	2.047	130	3,110
2018	2.092	113	2,862
2017	—	100	1,967
2016	—	109	2,418
2015	—	100	1,990

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #10,089Scopus Q2SCImago Profile

Scopus Coverage:1979-2026

•

Scopus Broad Areas:MedicinePharmacology, Toxicology and Pharmaceutics

Scopus Citation Rank (SJR)Q2

0.587

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2

Citations / Doc (2 years)

2.33

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$2,988 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations825

3-Year Documents325

Citable Documents296

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate46.0%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Pharmacology (medical)Q2

PharmacologyQ3

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 7.1%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

4区 (Zone 4)Medicine

Minor Category (Specific Field):

3区MEDICAL LABORATORY TECHNOLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Therapeutic Drug Monitoring (acronym: tdm, abbr: THER. DRUG MONIT, ISSN: 0163-4356) is a peer-reviewed international scholarly journal in the field of Medicine, published by Lippincott Williams and Wilkins Ltd. in United States since 1979. The periodical holds a Journal Impact Factor (JIF) of 2.30, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 0.587 (Q2), an H-index of 108.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 94 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $2,988 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.